Also categorized in BoardMoves:
Honest Company Diversifies Its Leadership With A Second Female Board Member
x hide permanently

Aprea Therapeutics Appoints Fouad Namouni, M.D. and Richard Peters, M.D., Ph.D. to Board of Directors

GlobeNewswire

Aprea Therapeutics Inc., (NASDAQ: APRE), a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein, today announced the appointments of Fouad Namouni, M.D. and Richard Peters, M.D., Ph.D. to its Board of Directors...

Mentions: Nasdaq Board of Directors Fouad Namouni